| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/JPET.105.097584 |
| P698 | PubMed publication ID | 16525037 |
| P2093 | author name string | Hong Cheng | |
| Chris Fraser | |||
| Yajun Xu | |||
| Danyi Wen | |||
| Michael Hepperle | |||
| Bruce D Jaffee | |||
| Geraldine Harriman | |||
| Lisa Schopf | |||
| Andrew Bielecki | |||
| Jennifer Dasilva | |||
| Timothy D Ocain | |||
| Yuhua Nong | |||
| Jennifer G Morgan | |||
| Marie Keaveney | |||
| Pranoti Gangurde | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human fibroblast | Q101404861 |
| mast cell | Q191989 | ||
| P304 | page(s) | 989-1001 | |
| P577 | publication date | 2006-03-08 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells | |
| P478 | volume | 317 |
| Q46197457 | 11th annual Inflammatory and Immune Diseases Drug Discovery and Development Summit 12-13 March 2007, San Francisco, USA. |
| Q37976467 | A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets |
| Q54379487 | A novel IKKα inhibitor, noraristeromycin, blocks the chronic inflammation associated with collagen-induced arthritis in mice. |
| Q35156421 | A novel carboline derivative inhibits nitric oxide formation in macrophages independent of effects on tumor necrosis factor α and interleukin-1β expression |
| Q33834752 | A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells |
| Q37036746 | Advances in targeting IKK and IKK-related kinases for cancer therapy |
| Q89422998 | Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3 |
| Q40440899 | B-cell-derived lymphotoxin promotes castration-resistant prostate cancer |
| Q37201984 | Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications |
| Q37291635 | Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells |
| Q90468258 | Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress |
| Q37615916 | Chemical biology of inflammatory cytokine signaling |
| Q33395224 | Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen |
| Q36794899 | Developments in the synovial biology field 2006. |
| Q39996123 | Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes. |
| Q36094024 | Dihydromyricetin suppresses inflammatory responses in vitro and in vivo through inhibition of IKKβ activity in macrophages |
| Q34454541 | Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques |
| Q33812773 | Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes |
| Q33737707 | Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation |
| Q34133753 | I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma |
| Q58113127 | IL-1-induced JAK/STAT signaling is antagonized by TGF-beta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q41575754 | Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers |
| Q37907354 | Inhibitory kappa B Kinases as targets for pharmacological regulation |
| Q38778339 | Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study |
| Q38724839 | Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti-inflammatory effects through blocking toll-like receptor 4 dimerization. |
| Q37447488 | IκB kinase b Mediating the Downregulation of p53 and p21 by Lipopolysaccharide in Human Papillomavirus 16+ Cervical Cancer Cells |
| Q90574004 | Latent, Immunosuppressive Nature of Poly(lactic-co-glycolic acid) Microparticles |
| Q35835370 | Lipopolysaccharide and hypoxia significantly alters interleukin-8 and macrophage chemoattractant protein-1 production by human fibroblasts but not fibrosis related factors. |
| Q48105513 | Long-acting β2-agonists promote glucocorticoid-mediated repression of NF-κB by enhancing expression of the feedback regulator TNFAIP3. |
| Q55463750 | Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients. |
| Q39563568 | Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways |
| Q38644746 | Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. |
| Q36544693 | Mutation of cysteine 46 in IKK-beta increases inflammatory responses |
| Q36709522 | NF-kappa B as a therapeutic target in autoimmune disease. |
| Q28546967 | Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences |
| Q90859276 | Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells |
| Q50872022 | Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13). |
| Q55171215 | Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function. |
| Q36204370 | Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase |
| Q37214209 | Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. |
| Q37308018 | Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. |
| Q36778047 | Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy |
| Q92050583 | The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition "Killing Two Birds with One Stone"? |
| Q49463915 | The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts |
| Q37781917 | Therapeutic opportunities in fibroblasts in inflammatory arthritis |
| Q41168560 | Total tanshinones exhibits anti-inflammatory effects through blocking TLR4 dimerization via the MyD88 pathway. |
| Q46667078 | Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth |
| Q64880703 | Tumour-Derived Laminin α5 (LAMA5) Promotes Colorectal Liver Metastasis Growth, Branching Angiogenesis and Notch Pathway Inhibition. |
| Q28268290 | Use of cell permeable NBD peptides for suppression of inflammation |
Search more.